Fayez Sarofim & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-3,075
| Closed | -$373K | – | 247 |
|
|
2017
Q1 | $373K | Sell |
3,075
-9,875
| -76% | -$1.2M | ﹤0.01% | 204 |
|
|
2016
Q4 | $1.58M | Sell |
12,950
-17,806
| -58% | -$2.18M | 0.01% | 135 |
|
|
2016
Q3 | $3.77M | Sell |
30,756
-306,225
| -91% | -$37.5M | 0.02% | 117 |
|
|
2016
Q2 | $39.5M | Sell |
336,981
-9,983
| -3% | -$1.17M | 0.22% | 68 |
|
|
2016
Q1 | $48.6M | Sell |
346,964
-2,199
| -0.6% | -$308K | 0.28% | 66 |
|
|
2015
Q4 | $66.1M | Buy |
349,163
+16,901
| +5% | +$3.2M | 0.38% | 65 |
|
|
2015
Q3 | $52.1M | Buy |
+332,262
| New | +$52.1M | 0.3% | 68 |
|